Evidence map›Paper›PMID 33804391›Full record

ReviewJournal of clinical medicine2021

Aortic Valve Disease and Associated Complex CAD: The Interventional Approach.

Federico Marin, Roberto Scarsini, Rafail A Kotronias, Dimitrios Terentes Printzios, Matthew K Burrage, Jonathan J H Bray, Jonathan L Ciofani, Gabriele Venturi, Michele Pighi, Giovanni L De Maria and 1 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Coronary calcifications, the Achilles heel in coronary interventions.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Federico MarinOxford Heart Centre, Oxford University Hospitals, NHS Trust, Oxford OX3 9DU, UK.ORCID 0000-0001-8776-6647
Roberto ScarsiniDepartment of Cardiology, University of Verona, 37129 Verona, Italy.
Rafail A KotroniasOxford Heart Centre, Oxford University Hospitals, NHS Trust, Oxford OX3 9DU, UK.ORCID 0000-0001-8132-6130
Dimitrios Terentes PrintziosOxford Heart Centre, Oxford University Hospitals, NHS Trust, Oxford OX3 9DU, UK.
Matthew K BurrageOxford Heart Centre, Oxford University Hospitals, NHS Trust, Oxford OX3 9DU, UK.ORCID 0000-0003-3837-8140
Jonathan J H BrayInstitute of Life Sciences 2, Swansea Bay University Health Board and Swansea University Medical School, SA2 8QA Swansea, UK.
Jonathan L CiofaniDepartment of Cardiology, Royal North Shore Hospital, 2065 Sydney, Australia.ORCID 0000-0003-4476-6051
Gabriele VenturiDepartment of Cardiology, University of Verona, 37129 Verona, Italy.
Michele PighiDepartment of Cardiology, University of Verona, 37129 Verona, Italy.
Giovanni L De MariaOxford Heart Centre, Oxford University Hospitals, NHS Trust, Oxford OX3 9DU, UK.
Adrian P BanningOxford Heart Centre, Oxford University Hospitals, NHS Trust, Oxford OX3 9DU, UK.ORCID 0000-0002-2842-7861

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary artery disease (CAD) is highly prevalent in patients with severe aortic stenosis (AS). The management of CAD is a central aspect of the work-up of patients undergoing transcatheter aortic valve implantation (TAVI), but few data are available on this field and the best percutaneous coronary intervention (PCI) practice is yet to be determined. A major challenge is the ability to elucidate the severity of bystander coronary stenosis independently of the severity of aortic valve stenosis and subsequent impact on blood flow. The prognostic role of CAD in patients undergoing TAVI is being still debated and the benefits and the best timing of PCI in this context are currently under evaluation. Additionally, PCI in the setting of advanced AS poses some technical challenges, due to the complex anatomy, risk of hemodynamic instability, and the increased risk of bleeding complications. This review aims to provide a comprehensive synthesis of the available literature on myocardial revascularization in patients with severe AS undergoing TAVI. This work can assist the Heart Team in individualizing decisions about myocardial revascularization, taking into account available diagnostic tools as well as the risks and benefits.

Indexed as

aortic stenosiscoronary artery diseasemyocardial revascularizationpercutaneous coronary intervention

Identifiers

PMID33804391
PMCPMC7957505

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.